FUNDAMENTALS |
MarketCap: |
75 252 mill
|
EPS: |
5.19
|
P/E: |
31.78
|
Earnings Date: |
Aug 06, 2024 |
SharesOutstanding: |
456.30 mill
|
Avg Daily Volume: |
3.76 mill
|
RATING
2024-05-08 |
S
|
Strong Buy
|
RATINGS |
Rating CashFlow: |
Buy
|
|
Return On Equity: |
Strong Buy
|
|
Return On Asset: |
Strong Buy
|
|
DE: |
Strong Buy
|
|
P/E: |
Buy
|
|
Price To Book: |
Strong Buy
|
|
QUARTER GROWTHS |
|
4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 |
Revenue | | | | | | |
Gr.Profit | | | | | | |
Ebit | | | | | | |
Asset | | | | | | |
Debt | | | | n/a | | |
PE RATIO: COMPANY / SECTOR |
2.06x
|
Company: PE 31.78 | sector: PE 15.43
|
PE RATIO: COMPANY / INDUSTRY |
1.16x
|
Company: PE 31.78 | industry: PE 27.41
|
DISCOUNTED CASH FLOW VALUE |
$106.85
(-35.21%)
$-58.07
|
Date: 2024-05-09
|
Expected Trading Range (DAY) |
$ 160.47 - 169.37
( +/- 2.70%)
|
ATR Model: 14 days
|
Insider Trading
Date |
Person |
Action |
Amount |
type |
2024-04-18 | Lagano Roxanne | Sell | 923 | Common Stock |
2024-04-05 | Lagano Roxanne | Buy | 281 | Phantom Stock Unit |
2024-04-05 | Mamilli Wafaa | Buy | 411 | Phantom Stock Unit |
2024-04-05 | Joseph Wetteny | Buy | 581 | Phantom Stock Unit |
2024-04-05 | Driscoll Rimma | Buy | 16 | Phantom Stock Unit |
INSIDER POWER |
-16.30
|
Last
100 transactions |
Buy:
87 523 | Sell:
122 271 |
Forecast:
16:00 - $165.01
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $165.01
Forecast 2: 16:00 - $165.01
Forecast 3: 16:00 - $165.01
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals |
RSI 21 |
|
SMA |
|
Trend |
|
Trend 2 |
|
Trend 3 |
|
MACD |
|
Volume Signals |
Price |
$164.92 (-2.10% )
|
Volume |
4.26 mill
|
Avg. Vol. |
3.76 mill
|
% of Avg. Vol |
113.33 %
|
Signal 1: |
|
Signal 2: |
|
Last 10 Buy & Sell Signals For ZTS
0 Signals |
Accuracy: 0.00% | Accuracy
Buy: 0.00% | Accuracy
Sell: 0.00%
Avg return
buy: 0.00 % | Avg return
sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.